Expanding the Clinical Spectrum of Osteogenesis Imperfecta Type V: 13 Additional Patients and Review
Osteogenesis imperfecta (OI) is an inherited connective tissue disorder characterized by bone fragility and is characterized by clinical and genetic heterogeneity. Previous studies showed that the same mutation (c.−14C> T) of the IFITM5 gene is responsible for autosomal dominant OI type V. Ho...
Main Authors: | Yang-Jia Cao, Zhe Wei, Hao Zhang, Zhen-Lin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fendo.2019.00375/full |
Similar Items
-
Expanding the phenotypic spectrum of osteogenesis imperfecta type V including heterotopic ossification of muscle origins and attachments
by: Pantelis Clewemar, et al.
Published: (2019-07-01) -
Dissecting the phenotypic variability of osteogenesis imperfecta
by: Nadia Garibaldi, et al.
Published: (2022-05-01) -
IFITM5-related (type V) osteogenesis imperfecta with evidence of perinatal involvement: A case report
by: Valentina Martínez-Montoya, et al.
Published: (2024-06-01) -
Osteogenesis imperfecta and dentinogenesis imperfecta: Clinical features and dental management
by: Chetna Grover, et al.
Published: (2022-01-01) -
IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients
by: Lidiia Zhytnik, et al.
Published: (2019-06-01)